A Phase 1, Pilot, Single-Dose, 4-Way Crossover Study to Compare the Pharmacokinetics of Caprylic Triglyceride Oil, AC-1202, AC-1204, and Axona on Ketone Body Production
Phase of Trial: Phase I
Latest Information Update: 13 Apr 2017
At a glance
- Drugs AC 1202 (Primary) ; AC 1204 (Primary)
- Indications Alzheimer's disease
- Focus Pharmacokinetics
- Sponsors Accera
- 05 Dec 2016 Status changed from active, no longer recruiting to completed.
- 21 Jul 2016 Status changed from recruiting to active, no longer recruiting.
- 19 Jul 2016 New trial record